Pegvisomant, developed by professor John Kopchick in 1987, shows potential to make treatment-resistant lung cancer cells more ...

Researchers have uncovered how proteins normally active only before birth can drive aggressive lung cancer, opening new ...

GSK plc GSK announced that Japan’s Ministry of Health, Labour and Welfare has granted Orphan Drug Designation (ODD) to ...

Lung cancer used to have grim outcomes but earlier detection is improving those odds. A new combined procedure with diagnosis and removal using two different robotic systems at Roper could change that ...

New research from the University of Virginia shows people who have serious cases of COVID or influenza face another risk ...

While smoking remains the leading risk factor, other contributors include secondhand smoke, air pollution, radon exposure and ...

Scientists from the VIB–KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, have ...

Severe covid and flu infections may raise the risk of developing lung cancer years later, researchers at the University of ...

The 2026 IASLC Targeted Therapies in Lung Cancer meeting brought together leading oncologists, surgeons, and patient ...

According to the American Lung Association, the national five-year lung cancer survival rate is about 29.7 percent. The ...

A mobile lung screening unit designed to give patients a better chance by detecting cancer early, has seen about 3,000 people ...

Mel McLaughlin and her late sister were both nonsmokers ...